Effect of a New Hydroxyethyl Starch (HES) Specification [6% HES (130/0.4)] on Blood and Plasma Volumes after Bleeding in 12 Healthy Male Volunteers

Author： Waitzinger J.

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.17, Iss.2, 1999-02, pp. : 119-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hydroxyethyl Starch (HES) [130/0.4], a New HES Specification: Pharmacokinetics and Safety after Multiple Infusions of 10% Solution in Healthy Volunteers

By Waitzinger J.

Drugs in R&D, Vol. 4, Iss. 3, 2003-01 ,pp. : 149-157

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4)] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers

By Waitzinger J.

Clinical Drug Investigation, Vol. 16, Iss. 2, 1998-08 ,pp. : 151-160

Adis International

Access to resources Recommend Favorite

Tissue Storage of 14 C-Labelled Hydroxyethyl Starch (HES) 130/0.4 and HES 200/0.5 after Repeated Intravenous Administration to Rats

By Leuschner J.

Drugs in R&D, Vol. 4, Iss. 6, 2003-01 ,pp. : 331-338

Adis International

Access to resources Recommend Favorite

Male-Female Differences in the Plasma, Liver and Tissue Esterase Hydrolysis of Lovastatin in Healthy Volunteers after a Single Oral Dose

By Vree T.B.

Clinical Drug Investigation, Vol. 22, Iss. 3, 2002-03 ,pp. : 181-190

Adis International

Access to resources Recommend Favorite

Volume Efficacy and Reduced Influence on Measures of Coagulation Using Hydroxyethyl Starch 130/0.4 (6%) with an Optimised in Vivo Molecular Weight in Orthopaedic Surgery: A Randomised, Double-Blind Study

By Jungheinrich C.

Drugs in R&D, Vol. 5, Iss. 1, 2004-01 ,pp. : 1-9

Adis International

Access to resources Recommend Favorite